Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a pain-like state

Japanese Journal of Neuropsychopharmacology

Volumn 26, Issue 5-6, 2006, Pages 183-192

  Imai, Satoshi ^a   Narita, Minoru ^a   Hashimoto, Seiko ^a   Nakamura, Atsushi ^a   Miyoshi, Kan ^a   Nozaki, Hiroyuki ^a   Hareyama, Nana ^a   Takagi, Tomoe ^a   Suzuki, Masami ^a   Narita, Michiko ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Anti hyperalgesic effect; Fentanyl; Morphine; Opioid tolerance; Splice variant dependent opioid receptor subtypes

Indexed keywords

FENTANYL; FREUND ADJUVANT; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 2A;

ANALGESIC ACTIVITY; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG TOLERANCE; DRUG USE; HYPERALGESIA; LONG TERM CARE; MALE; MOUSE; NONHUMAN;

EID: 33846116698     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ammon-Treiber, S. and Hollt, V. (2005) Morphine-induced changes of gene expression in the brain. Addict Biol, 10: 81-89.
2. Chakrabarti, S., Regec, A. and Gintzler, A.R. (2005) Chronic morphine acts via a protein kinase Cγ-Gβ-adenylyl cyclase complex to augment phosphorylation of Gβ and Gβγ stimulatory adenylyl cyclase signaling. Brain Res Mol Brain Res, 138: 94-103.
3. Claing, A., Laporte, S. A., Caron, M. G. and Lefkowitz, R. J. (2002) Endocytosis of G protein-coupled receptors: Roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol, 66: 61-79.
4. Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J. and Caron, M. G. (2000) Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci, 27: 107-144.
5. Hylden, J. L. and Wilcox, G. L. (1980) Intrathecal morphine in mice: A new technique. Eur J Pharmacol, 67: 313-316.
6. Ikeda, K., Ichikawa, T., Kobayashi, T., Kumanishi, T., Oike, S. and Yano, R. (1999) Unique behavioural phenotypes of recombinant-inbred CXBK mice: Partial deficiency of sensitivity to μ- and κ-agonists. Neurosci Res 34: 149-155.
7. Koch, T., Schulz, S., Schroder, H. Wolf, R., Raulf, E. and Hollt, V. (1998) Carboxyl-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalizaiton and receptor resensitization. J Biol Chem, 273: 13652-13657.
8. Minnis, J. G., Patierno, S., Kohlmeier, S. E., Brecha, N. C., Tonini, M. and Sternini, C. (2003) Ligand-induced μ opioid receptor endocytosis and recycling in enteric neurons. Neuroscience, 119: 33-42.
9. 5]enkephalin. J Neurosci, 21: 3715-3720.
10. Narita, M., Mizoguchi, H., Suzuki, T., Narita, M., Dun, N.J., Imai, S., Yajima, Y., Nagase, H., Suzuki, T. and Tseng, L. F. (2001b) Enhanced μ-opioid responses in the spinal cord of mice lacking protein kinase Cγ isoform. J Biol Chem, 18: 15409-15414.
11. Narita, M., Imai, S., Ozaki, S., Suzuki, M., Narita, M. and Suzuki, T. (2003) Reduced expression of a novel μ-opioid receptor (MOR) subtype MOR-1B in CXBK mice: Implications of MOR-1B in the expression of MOR-mediated responses. Eur J Neurosci, 18: 3193-3198.
12. Pan, Y.-X., Xu, J., Mahurter, L., Bolan, E., Xu, M. and Pasternak, G.W. (2001) Generation of the μ opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci USA, 98: 14084-14089.
13. Pasternak, G. W. (2001) Insights into μ opioid pharmacology: The role of μ opioid receptor subtypes. Life Sci, 68: 2213-2219.
14. Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I. and Reisine, T. (1994) Pharmacological characterization of the cloned κ-, δ- and μ-opioid receptors. Mol Pharmacol, 45: 330-334.
15. Runnegar, M., Wei, X., Berndt, N. and Hamm-Alvarez, S. F. (1997) Transferrin receptor recycling in rat hepatocytes is regulated by protein phosphatase 2A, possibly through effects on microtubule-dependent transport. Hepatology, 26: 176-185.
16. Schulz, S., Mayer, D., Pfeiffer, M., Stumm, R., Koch, T. and Hollt, V. (2004) Morphine induces terminal μ-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J, 23: 3282-3289.
17. Ventafridda, V. and De Conno, F. (1981) Organizing pain control and rehabilitation service in a cancer centre. Int Rehabil Med, 3: 149-154.
18. Ward, E. S., Martinez, C., Vaccaro, C., Zhou, J., Tang, Q. and Ober, R. J. (2005) From sorting endosomes to exocytosis: Association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling. Mol Biol Cell, 16: 2028-2038.
19. Wolf, R., Koch, T., Schulz, S., Klutzny, M., Schroder, H., Raulf, E., Buhling, F. and Hollt, V. (1999) Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat μ opioid receptor. Mol Pharmacol, 55: 263-268.
20. Yoshikawa, M., Nakayama, H., Ueno, S., Hirano, M., Hatanaka, H. and Furuya, H. (2000) Chronic fentanyl treatments induce the upregulation of μ opioid receptor mRNA in rat pheochromocytoma cells. Brain Res, 859: 217-223.
21. Zimprich, A., Simon, T. and Hollt, V. (1995) Cloning and expression of and isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett, 359: 142-146.